ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 924

Characteristics of Pain Flares in Knee Osteoarthritis

Susan L. Murphy1, Angela K. Lyden2, Arnold Gammaitoni3, David A. Williams4, Daniel J. Clauw5, J. Ryan Scott6 and Kristine Phillips7, 1Physical Medicine & Rehabilitation, University of Michigan, Ann Arbor, MI, 2Department of Anesthesiology, University of Michigan, Ann Arbor, MI, 3Zogenix, Inc, San Diego, CA, 4Chronic Pain & Fatigue Rsch Ctr, Univ of MI Hlth System-Lobby M, Ann Arbor, MI, 5Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 6Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 7Division of Rheumatology, University of Michigan, Ann Arbor, MI

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: osteoarthritis and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pain: Basic and Clinical Aspects I

Session Type: Abstract Submissions (ACR)

Background/Purpose: For inclusion in osteoarthritis clinical trials, participants often need to have a pain ‘flare’, usually defined as a pain increase over a period of time prior to study entry. Outside of clinical trial settings, there is no consensus regarding what constitutes a pain flare. The purpose of this study was to examine how individuals with knee osteoarthritis experience pain flares and their impact on daily living.

Methods: 45 participants (64 + 10 years; 55% female) with knee osteoarthritis underwent a baseline clinic visit as part of a larger pharmaceutical trial. At this visit, symptom measures were collected and participants were trained in procedures to collect data using a wrist-worn accelerometer in a 7-day home monitoring period. Participants wore the Actiwatch-Score and entered ratings of pain severity (0-10 scale) eight times per day. They were also asked to provide information at the end of each day in a logbook. Participants were asked to provide a definition of a pain flare and used that definition to indicate in the logbook if they experienced a pain flare that day and what they were doing when it occurred. Pain variability was calculated as the standard deviation of the pain ratings over the 7 day period. We hypothesized that pain flares and pain variability would be strongly related.

Results: When asked to define ‘pain flare’, descriptors of ‘sharp’ and ‘increase in pain’ were used by 30% and 21% of the sample respectively. Other descriptors included ‘intense/severe’, ‘electrical’ and various descriptors (e.g., twinge, stabbing, pulsation). Pain flares were most often described to be of short duration. During the home monitoring period, 77% of the sample experienced at least one pain flare and the mean was 2.2 + 2.0. Pain flares were most strongly associated with their worst daily pain (r = .51), followed by weekly average pain severity (r = .42), pain interference on the Brief Pain Inventory (r= .39), and WOMAC pain scale (r= .37). When asked to describe what they were doing when a pain flare occurred, participants most frequently mentioned activity-related causes (stair climbing, walking, shopping), while very few mentioned stiffness due to inactivity or being awakened by night pain. Pain flares were not significantly associated with pain variability (r = .12) or with neuropathic pain as measured by the PainDetect (r= .09); however PainDetect was most strongly correlated with WOMAC Pain (r=0.60), WOMAC Physical Function (r=0.57), and BPI severity (r=0.60).   

Conclusion: Pain flares occurred frequently over a week for people with osteoarthritis, were of short duration, and were most often experienced during activities. Interestingly, pain flares were not associated with pain variability. Although pain flares and pain variability may be activity-related, WOMAC subscales, which asked about pain or function during activities, were most strongly associated with a neuropathic component to pain. These findings provide further insight into the pain experience for people with knee osteoarthritis. Pain flares appear to be characterized by researchers and individuals with knee osteoarthritis in a variety of ways suggesting the need for additional research in this area.


Disclosure:

S. L. Murphy,
None;

A. K. Lyden,
None;

A. Gammaitoni,

Zars Research,

3;

D. A. Williams,

Pfizer, Inc,

2;

D. J. Clauw,
None;

J. R. Scott,
None;

K. Phillips,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-pain-flares-in-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology